A Study of Atezolizumab in Unresectable or Advaced Malignant Pleural Mesothelioma

Summary

This is a national, single arm, phase II trial in patients with diagnosis of unresectable or advanced malignant pleural mesothelioma who experienced progression after platinum-based chemotherapy.

Timeline

Start

2020-08

Primary completion

2020-08

Completion

2020-08

Outcome

Outcome not reported

Stopped: “Publication of study results of ICI use in MPM as first line therapy”

Drugs

Indications